Conference Programme [International Conference on AIDS (16th: 2006: Toronto, Canada)]

-I
I r c o
Meas
Monay

Wednesday 16 August
Poster Exhibition 10:15 - 18:30

Wednesday
Poster
Exhibition
El
UT s

WEPE0120 Comprehensive care of HIV-infected
adolescents in sub-Saharan Africa:
monitoring growth, development and
recovery while on antiretroviral therapy
S. Bakeera-Kitaka', M. McKellar', C. Snider,
A. Kekitiinwa', T. Piloya', J.-M. Matovu', E.
Katabira', M. Sande', A. Ronald1
'Uganda, 2United States
WEPE0121 Long-term efficacy, safety, and
tolerability of indinavir-based therapy
in nucleoside experienced HIV-1 -infected patients in a resource limited
setting: 272 weeks follow up of HIVNAT 005 study
A. Avihingsanon', 5. Kerr, M. Boyd2, C.
Ungsedhapand', C. Duncombe', S. Ubolyam',
K. Pussadee', K. Ruxrungtham', J. Lange3, D.
Cooper, P. Phanuphak', HIV-NAT 006 Study
Team
'Thailand, 2Australia, 3Netherlands
WEPE0122 Assessing programme continuation
rates through life table analysis - an
innovative application for resourcelimited programme settings
I. WanyekiP, J. Fielder', k. Foreit2
'Kenya, 2United States
WEPE0123 12-month outcomes among HIVinfected individuals starting
antiretroviral therapy in South Africa
S. Charalambous', K. Fielding2, A. Stenson',
L. Pemba', C. Innes', S. Senoge', P.
Seatlanyane', R. Wood', D. Martin', A.
Grant2, G. Churchyard'
'South Africa, 2United Kingdom
WEPE0124 Risk factors for death after ART
initiation in poor setting countries
P.Leger. P. Severe, J. Julmiste, M. Theliard,
M. Charles, E. Michel, J. Davilmar, P. Vachon,
J.W. Pape
Haiti
WEPE0125 Efficacy of mDOT at improving
virological outcome among patients
taking HAART in community and
hospital based cohorts in Mali and
Burkina Faso
S. Ag Aboubacrine', C. Boileau', A. Syll//a, S.
Koala3, P. Niamba3, J. Drabo3, M. Ma/ga', A.
OuermPi, S. Rashed2, M.-V. Zunzunegui, M.
Syll//a, C. Tremblay2, V.-K. Nguyen', Pro-ARV
Group
'Mali, 2Canada, 3Burkina Faso
WEPE0126 HIV care clinics as a platform for rapid
scale up of art programmes
F Miruka', B. Marston', N_. Lennah, 1.
Gesami', J. Otieno', J. Wariero', p. Oguta',
M. Aluoch', L. Ngere', A. Ajwang', K.
De Cock'
'Kenya, 2United States

WEPE0127 Reaching the poor - changes of
patients' characteristics after
introduction of free ARV at the
lighthouse at Kamuzu central hospital,
Lilongwe, Malawi
E. Mhango, S. Phiri, M. Boxshall, M.
Hochgesang, M. Hosseinipour, J. Chiwoko, A.
Harries, R. Weigel
Malawi
WEPE0128 Rapid scale up of antiretroviral therapy
with health worker HIV training and
capacity building, Hubei Province, China
F. Zhan', C. Teter', X. GuiP, P. Liu', R. Sherer2
'China, People's Republic of, 2United States
WEPE0129 Overcoming problems with regards
to paediatric administration -
disadvantages of using oral liquid
formulations and the recommendations
of the Perinatal HIV Research Unit
(PHRU) Pharmacy, South Africa
F. Mayat
South Africa
WEPE0130 Antiretroviral durability and tolerability
in HIV-infected adults living in urban
Kenya
C. Hawkins', C. Achenbach', W. Fryda2, D.
Ngare2, R. Murphy'
'United States, 2Kenya
WEPE0131 Evaluation of treatment outcomes and
adherence among patients receiving
antiretroviral therapy in the conflictaffected region of north Uganda
A. Rigon', B. Nattabi2, B. Pido2, C. Pierotti2,
L. Ojom2, F. Ciantia2, M. Fabiani', S. Declich',
G. Gandolfo', D. D'avola', G. MottiniP, Z.
Yoti, R. Ocakacon'
'Italy, 2Uganda
WEPE0132 Clinical practices impacting the
durability of HAART in resource-limited
settings: a five-year South African
managed healthcare study
D. Sifris, A. van Bassen, J. Myhre
South Africa
WEPE0133 Mechanism of CD4+ t cell depletion
in patients exposed to tenofovir plus
didanosine
C. de Mendoza', J.M. Benito', N. Zahonero',
A. Cascajero', M. de Baar, P. Barreiro', 3J.
Gonzalez-Lahoz', V. Soriano'
'Spain, 2Netherlands (TBC)
WEPE0135 The effectiveness of a dedicated service
for managing lipodystrophy
L. Ratcliffe, P. Lewthwaite, E.G.L. Wilkins
United Kingdom
WEPE0136 Longitudinal increases in waist
circumference are associated with
HIV-serostatus, independent of
antiretroviral therapy in the multicenter
AIDS cohort study
T. Brown, Z. Wang, H. Chu, F. Palella, L.
Kingsley, M. Witt, A. Dobs
United States

XVI INTERNATIONAL AIDS CONFERENCE * 13-18 AUGUST 2006 * TORONTO CANADA * CONFERENCE PROGRAMME